Showing results (61-70 of 776) with videos related to
Sort By:
Pageof 78
Lancet (London, England)|November 16, 2004
Delayed graft function in kidney transplantationNorberto Perico, Dario Cattaneo, Mohamed H Sayegh, et al.Thescientificworldjournal|May 27, 2009
Low mortality and key aspects of delivery of care for end-stage renal disease in ItalyAlexander Lauder, Arrigo Schieppati, Ferruccio Conte, et al.Nature Reviews. Nephrology|April 2, 2022
Glomerular hyperfiltrationMonica Cortinovis, Norberto Perico, Piero Ruggenenti, et al.Kidney International|August 8, 2002
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantationDario Cattaneo, Norberto Perico, Flavio Gaspari, et al.Personalized Medicine|May 26, 2018
Pharmacogenetics and pharmacogenomics of immunosuppressive agents: perspective for individualized therapyDario Cattaneo, Anna Tankiewicz, Simona Merlini, et al.Transplantation|October 8, 2005
Cyclosporine formulation and Kaposi's sarcoma after renal transplantationDario Cattaneo, Eliana Gotti, Norberto Perico, et al.Scientific Reports|March 22, 2018
Early and late scanning electron microscopy findings in diabetic kidney diseaseSara Conti, Norberto Perico, Rubina Novelli, et al.Journal of Clinical Pharmacology|June 4, 2009
Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimenDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2004
Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic reviewAnnalisa Perna, Arrigo Schieppati, Javier Zamora, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 12, 2007
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipientsDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.Pageof 78